Peer-influenced content. Sources you trust. No registration required. This is HCN.
Renal & Urology News
A randomized noninferiority trial involving 648 men with MRI-visible prostate lesions found that cognitive fusion biopsy achieved clinically significant prostate cancer detection rates similar to software-based fusion biopsy. Subgroup analyses suggested body mass index may influence the relative performance of each approach.
Oncology, Medical July 29th 2026
Annals of Internal Medicine
A two-year analysis of 12,670 screened men found that the Stockholm3 risk model detected more clinically significant prostate cancers than PSA testing alone, primarily through fewer false-negative results. The findings suggest improved screening discrimination, although follow-up remains limited to two years.
Medical News Today (MNT)
A multivariable screening test detects 90% of clinically significant prostate cancers vs 74% with PSA alone, suggesting PSA thresholds may miss aggressive disease despite similar false-positive rates.
Oncology, Medical July 13th 2026
Healthline
A randomized phase II trial in 240 premenopausal women evaluated whether low-dose (Z)-endoxifen could reduce mammographic breast density with improved tolerability compared with standard tamoxifen prevention regimens.
Family Medicine/General Practice May 20th 2026
MDLinx
A widely shared r/medicine thread drew candid, self-identified physician commentary on which specialties absorb the most interprofessional scrutiny, with emergency medicine and primary care drawing the heaviest fire.
Anesthesiology May 11th 2026
The American College of Physicians issued updated breast cancer screening guidance recommending biennial mammography for average-risk women aged 50 to 74, with shared decision-making for those 40 to 49 and discontinuation discussions after 74.
Family Medicine/General Practice May 6th 2026